INS and Insulin resistance: Similarly, T1DM was associated with an increased IgAN risk in the MVMR analyses with statistical power [i.e., OR: 1.37, 95% CI: 1.08–1.74, adjusted for triglyceride (TG); OR: 1.38, 95% CI: 1.13–1.71, adjusted for fasting insulin (FI); OR: 1.42, 95% CI: 1.14–1.77, adjusted for fasting blood glucose (FBG); OR: 1.42, 95% CI: 1.15–1.76, adjusted for homeostasis model assessment of beta-cell function (HOMA-B); OR: 1.39, 95% CI: 1.12–1.72, adjusted for HOMA of insulin resistance (HOMA-IR); OR: 1.39, 95% CI: 1.12–1.73, adjusted for glycated hemoglobin (HbA1c)] (Table 3).